{"ticker": {"uuid": "1c7e4004-6274-47ca-9a0b-8d20c6efbfa5", "symbol": "SPTX", "name": "Seaport Therapeutics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Seaport Therapeutics (SPTX) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1CMXpteEp1WXBzWV9MVlhjaHRZS2hqSm9uaFVpQmFrNGw3U0ctQ2sxT2pCLTVINnNhUkhURTFHelljMkNpUlIyUkpqTWkzeERxYkVOTmRXc0tnRERNWVU1dU1LZE1fdw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-22T22:36:57+00:00", "published_display": "22 Jul 2026 22:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Seaport Therapeutics (NASDAQ:SPTX) Stock Rating Upgraded by HC Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPUXoyQnBqZEtLbGtnSlViRVM2eFlRMmlPeTdfTnNZMHB0OEFQbTZYVlllX0U4R000a3h6R1NZZEJidTBOUkQzSnkxMTdWZkJqNkR6V1pkbExOQzB2TFU2WU9pajRsWVFITkxXVU1WV1pWUU9DdjZ3SkJhQ25DTmNaOTJyV1FhZngwOVRWV3NSZk9wTEdYWWZYN19QS1ZoMzhVRGtZRTd6Ni11ODNsbjNXWXlzOFF1bFZGXzJONmctaHdyQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T11:12:25+00:00", "published_display": "16 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics stock initiated at buy by H.C. Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOLTlHT2hhRVZodkpubUtiQlg0c19LZ0FPay1BM29OSWxjdkhLX0loUldoOXNLTlFzVlNOdThMbm1JaDlZTm00a083UzN4elR5b1NZc0QxZWMzeGdoSkQ0RWxRdUROUFpYcDF4SWJERjE0WERQTkRDczUzTFBFRWZnblk2d0xUdGdRV0ZLZnlKOFprUDBRd2M2N3ZLekdHVVNlbkdYYkZWcU1XYjJMS0hnTk03cmtlc1FIN2pwbA?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T12:24:54+00:00", "published_display": "15 Jul 2026 12:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Consensus Rating of \"Hold\" from Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQSFIyX1o2bnZjT2Y0UzBHOFhRemZQeDA1amd6ekNXT2NlRWVCQTlkTUpXbTBIY2dtZzgzZDB2NkFhTG9sTVdZZmE3U3RqWXJRTnB4M3VCUGlxVHJXVTM1R2VoanhCdjRqX2lZZlBiUE5lOU9oOEg5X2NSTzlBelRLME5wX25WWXRXUE1MakxkTk1uODQ3cHdZMC11YmRsampiUk5HYTJkdjN6eXZuUXQyaklWdzB6eF9LMXdjWDI2Tm9BOHVtNm5nVEhqd0dmU2p1UVJZ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T08:20:58+00:00", "published_display": "15 Jul 2026 08:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to earnings forward of Seaport Therapeutics, Inc. \u2013 NASDAQ:SPTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOUjFlTlROZFFpbk1scVZhcXVGYVFVVXMzSFpDUTk4blgxbXYyTlBZbm9tdlBvR21zblNHbXROSkl2STByU2JqaGp1NDlSc2N4ODZVSWxhWk5EUF9uR3hzT244RVgzd1RjaFljRUpWSl9HQUc4b2Y1ODVPTHl5eEZtUEpqOWRMb0FET002bXl4WE5wdm5mcjdUNUtnd29La2trSEE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T01:32:40+00:00", "published_display": "05 Jul 2026 01:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 24, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQcDU0bTVBU2tnRkw5RUlHQXBCaHZMU0Y5Rzd2Q19UeVFBWEM5cjV5Vks4Tl9iSy1YLUEtZENkcXJxeENqZ0Z0YzhnUGk0dHRxS3pael9rd005U3pRNXJaMHJjTk5hUXZtMXhZODlQYWtBN0Z1N0pTZVo2eEMtckNEcQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SPCX Stock (SPTX) Opinions on post-IPO performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQQkpxTW00S0Vpbm9haG1IUWJIZW9CVUpJYlpDMUd3cTA0TlFTYnVicXdhS2plWkxNQUZCYVoxRHcwNjhkM2Z2Wkl2SW1NYzdib2hSMDRiZlVKcjNKRWZoTnNDMHdHSnlpN1RjLTh6TzdhbG9nUDNJMmlnNEZUa1RHanptNlY1bENyb2o4R2s5OG8?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo\u2122 in Healthy Volunteers", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/puretech-founded-entity-seaport-therapeutics-060000179.html", "source_name": "Business Wire", "published_at": "2026-06-09T06:00:00+00:00", "published_display": "09 Jun 2026 06:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Q1 Net Loss Widens", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-q1-net-loss-113204320.html", "source_name": "MT Newswires", "published_at": "2026-06-08T11:32:04+00:00", "published_display": "08 Jun 2026 11:32", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-reports-first-quarter-110500729.html", "source_name": "Business Wire", "published_at": "2026-06-08T11:05:00+00:00", "published_display": "08 Jun 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo\u2122 in Healthy Volunteers", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-reports-positive-multiple-110000111.html", "source_name": "Business Wire", "published_at": "2026-06-08T11:00:00+00:00", "published_display": "08 Jun 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics reports Q1 2026 financials and pipeline progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNZ2lFTHVBZnFKOXRyMVJScFBrMUVEb3BzUzFmUnV1aV81SHRDQXRMSVQzMl83d1VlaDhQMVo1V0xhUUxUMEZ6Q2Zub1VET0hpSy10Slc1NkFaOGdBZGI5SXgyLUc4UURqdDg0R0tIcFpkSjNObm5UZ2xjS3lqYWw2ME44QmJIQQ?oc=5", "source_name": "grafa.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics to Participate in Two Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-participate-two-upcoming-110000262.html", "source_name": "Business Wire", "published_at": "2026-06-01T11:00:00+00:00", "published_display": "01 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5yX3VBVjZ2VWktenFoVVZGb0hQMm80aE0tcGt2ek1zdDNPOW50RkRNRXM2dThzYThOYlBleG9EZnJ3TjgzaTZwMnZZUTlqMzhCbW45SnVmWUFxU0RtYzhuTjVKNkNEdw?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-26T12:07:48+00:00", "published_display": "26 May 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Seaport Therapeutics stock coverage citing platform validation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNcUI3T1RCU1VrVGs0S3Z1VjFIVUlKdFlqVVN1aXo5dklfNW52akZHTTU0dFA5aDdjWk0ybU9lMG80UnZxcEh4WnI3dHRaRHozQndDcmhmQ25oMUZBak83eHN2TnIzcFlQaExEckhEREE5VnNxemxRMmljcW9uOWZFdEdhN2VoSHdKY0RQdk1jc2h4VjA2b1E5alRqQlJKX09QZktxcHJxN2wwUG1idjBRNFNyczh4QkktcDJyUGlmYkJMRmdySHljZC1BaTVXWHluUUt1ZXV6aU9tbDRNdElB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Stock markets resemble peak of dot-com bubble, warns Burry", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNQ2U0dlRDV25wVWs0THJoY0l5U1pMYmdiVkpfUUhoTUxSdjJndElCX1l1V2tNamRIcWhJaEk3eUxXeWRSTGFTb19aR3FvTUZhV05mM1RySUlaWE54Tmd5VlpVWm9KV1ZXR1NGYjFxMDRuQjhZODcxU0RjcnVWNUdHTng4Q1hCcHFydW1NUnp0UEdJRkJzeGFSel85ZWFoZDQxZnZldS10Mk9YV3VIVTV2akJYLWE0VUE?oc=5", "source_name": "Irish Independent", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBKU0lRRDk5Z19uT1B0aTVKcV9ucGtHVDRTQnA1ekxEZTB1NWtwc3JrVWlWeEJBNkFmaTB3RVl6RjE1eUJvamJMb1F1NGRmdEpu?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-04T23:22:23+00:00", "published_display": "04 May 2026 23:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics, Inc (SPTX) Stock Price Today: $20.10", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBDVGJORUVuQmsyN2tPLWR3bmRYcER1bWxsdFNjU2Vra21fcFptUFZpWXZTekR0RlVVLTR5bW5rSC1hTldTXzNEejZOWHNISk1FZFVvX0xsYw?oc=5", "source_name": "Gotrade", "published_at": "2026-05-04T19:48:25+00:00", "published_display": "04 May 2026 19:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9GSnRyNkhiZl9lYjBRemg0QlZ5ZklsRS15TWJodW5ORXlRWnlLS1FoTUVTWVRkZDFkXzlDdzRTSzBjdmh6Ql93c2o5RzNXeVU4NGY0RHBVamRnenlXOUgzZGxtNmNIZDZqdldpajFkeHZFSEpFaHc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-04T15:33:22+00:00", "published_display": "04 May 2026 15:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQSy1hbVAtWjUzOFprWWs0bkFGekYxUmhpT2FRWTZmVVQ1eXdwVC1MUmZreDNYR3hpSGpYZ3BaYlJjcnhmX1BsQmJGWDcyNENjQXpFYndWd0RqRVR4TXJaZWxKeGZ2OGhPYUJzTmZJQTVUTEN6UzZFa0hCQWU1YlpvMHZBUU45MkZ4US1lcGVzZXBZR0FRX3VhdDF6aGoxRjBRSjhZdEVBUU9qV041S293?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9raUYxX2pFZnktdWEyZXZVdmVIYlo2eThTYVhCM3RPb0FGbS12bDM2a1lVQnRiRlhJNWZUZF9nVTJqN2RuWS03dGlwdGRlOGFOU2pEVnhEbzZrQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T23:25:39+00:00", "published_display": "02 May 2026 23:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Rings the Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1Bb0psVUZyelBId2hVVUFZbUpQdkJCOEFnYm9BVnk2U29SSDY4SHJDVG04ZmZNUmdQejRTNXBUdW5BdGsyTzN1QVpfRWNGNUxycXRPMURReFBvSFdpUGYyTVhNMm5TaDlfYlVJQ0I5RU8xbXgxUEZEXw?oc=5", "source_name": "Nasdaq", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab price upsized IPOs eyeing $550M in proceeds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1RNC0tOXZWMktULU5ad1VkZHZzTlpsSFZobi04clIzblNQcFdCU1ltT1dKNGd2c0tUdDFaMURnUTVycC1rYzd5amFsdmQ4Y296Uk9kZU84TVVRQk0yY1lrOGtzQjNHUC1LZTA4bnJRV0tiVjREaDNzS0FR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPeDgtMUt3RVUzaDBTTGxHWmthOGlRNTJRM0xOYVFlaEVDOG0tVXYxM216Q0VwLUI5SnNIV1VRSTFQdWxNSUtOdmxyVDZiOHhsZWZNTHhadzliOXl1RWszR3VXT1U3RkJ2QWVyemNXTlFfOHdGcUthdUtBbmN0OVNlbzh4cmtKVU45ZUR5TzlvekVfbnNOZjhKZ0pwejlZR2pDM3huUWdndDQxTkhoN2hLZGRZdGRIb3ZHczhwMlBkdTFWREYtWjdNRzlR?oc=5", "source_name": "Business Wire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE81ZVdma2hyMUdWZ0FBNjBKamJOM1pvY1p6LTBqbURqWUU4bS1QcEp5UFNKMThPc3hvNVRkOUtVcVhkLXFuTk9kLUU4Q2tVZzNv?oc=5", "source_name": "CNN", "published_at": "2026-04-28T17:29:39+00:00", "published_display": "28 Apr 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab launch US IPOs as biotech listings gather momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPTnlOQkR4VkhDYnZXbHlLTjktQ3c3UGlKX0dMdzNFcEJQcDczREs5alNJRDFwNWhqajZaSjNCS3k2NTIzZVpqVG9zUy05QnNETklpYjNDclJQUG5vRmg0Y25IZ1B3Z3JndVdqUmpYN1c4eVljWkFxbHVqc0VQZHJ3Sy11TGZBUU1OWjNWVlk0WjQ2SnFLZ215TXNNRm15eHZWaU9wMU1tQWlJX2d1R2hLbkRpVHZjMjMtSW4wMVpCTFhNR1k?oc=5", "source_name": "Reuters", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drug developer Seaport Therapeutics seeks up to $212M in US IPO (SPTX:Pending)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOQjFvbnR4SnF3TnVsRElFRGdtblFKR0x5eWMzcDJLdGlpR29VbDRYU3B0MlVkeXM2Z1pUVmM4TTFJRkJZVlNvVjZQTlZQNm4xSTMxRGJYYmxvaUFjSUFscDdDOW5aQU9yRllZa3JGSnk5UjUwaWUwaW5oSDhrWll1aTFDd3RIMWRiRVZ4Qk5pWDkwQUUwQlJyOGdxdGhqQWF1cUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SPTX Stock Price and Chart \u2014 NASDAQ:SPTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1OY0hLNmhLSGY5OEpES1daVW5oV3FJY3pBbFdJMEZsRHFvUFJxaHdqNm4tNk1BdHBkVWJsNEVoenpGTVFEU0g0X19MRnIzbFhhVEhueFFJdXhxV1Ji?oc=5", "source_name": "TradingView", "published_at": "2026-04-14T10:27:06+00:00", "published_display": "14 Apr 2026 10:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Seaport Therapeutics (SPTX) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1CMXpteEp1WXBzWV9MVlhjaHRZS2hqSm9uaFVpQmFrNGw3U0ctQ2sxT2pCLTVINnNhUkhURTFHelljMkNpUlIyUkpqTWkzeERxYkVOTmRXc0tnRERNWVU1dU1LZE1fdw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-22T22:36:57+00:00", "published_display": "22 Jul 2026 22:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (NASDAQ:SPTX) Stock Rating Upgraded by HC Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPUXoyQnBqZEtLbGtnSlViRVM2eFlRMmlPeTdfTnNZMHB0OEFQbTZYVlllX0U4R000a3h6R1NZZEJidTBOUkQzSnkxMTdWZkJqNkR6V1pkbExOQzB2TFU2WU9pajRsWVFITkxXVU1WV1pWUU9DdjZ3SkJhQ25DTmNaOTJyV1FhZngwOVRWV3NSZk9wTEdYWWZYN19QS1ZoMzhVRGtZRTd6Ni11ODNsbjNXWXlzOFF1bFZGXzJONmctaHdyQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T11:12:25+00:00", "published_display": "16 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics stock initiated at buy by H.C. Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOLTlHT2hhRVZodkpubUtiQlg0c19LZ0FPay1BM29OSWxjdkhLX0loUldoOXNLTlFzVlNOdThMbm1JaDlZTm00a083UzN4elR5b1NZc0QxZWMzeGdoSkQ0RWxRdUROUFpYcDF4SWJERjE0WERQTkRDczUzTFBFRWZnblk2d0xUdGdRV0ZLZnlKOFprUDBRd2M2N3ZLekdHVVNlbkdYYkZWcU1XYjJMS0hnTk03cmtlc1FIN2pwbA?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T12:24:54+00:00", "published_display": "15 Jul 2026 12:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Consensus Rating of \"Hold\" from Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQSFIyX1o2bnZjT2Y0UzBHOFhRemZQeDA1amd6ekNXT2NlRWVCQTlkTUpXbTBIY2dtZzgzZDB2NkFhTG9sTVdZZmE3U3RqWXJRTnB4M3VCUGlxVHJXVTM1R2VoanhCdjRqX2lZZlBiUE5lOU9oOEg5X2NSTzlBelRLME5wX25WWXRXUE1MakxkTk1uODQ3cHdZMC11YmRsampiUk5HYTJkdjN6eXZuUXQyaklWdzB6eF9LMXdjWDI2Tm9BOHVtNm5nVEhqd0dmU2p1UVJZ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T08:20:58+00:00", "published_display": "15 Jul 2026 08:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Seaport Therapeutics, Inc. \u2013 NASDAQ:SPTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOUjFlTlROZFFpbk1scVZhcXVGYVFVVXMzSFpDUTk4blgxbXYyTlBZbm9tdlBvR21zblNHbXROSkl2STByU2JqaGp1NDlSc2N4ODZVSWxhWk5EUF9uR3hzT244RVgzd1RjaFljRUpWSl9HQUc4b2Y1ODVPTHl5eEZtUEpqOWRMb0FET002bXl4WE5wdm5mcjdUNUtnd29La2trSEE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T01:32:40+00:00", "published_display": "05 Jul 2026 01:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 24, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQcDU0bTVBU2tnRkw5RUlHQXBCaHZMU0Y5Rzd2Q19UeVFBWEM5cjV5Vks4Tl9iSy1YLUEtZENkcXJxeENqZ0Z0YzhnUGk0dHRxS3pael9rd005U3pRNXJaMHJjTk5hUXZtMXhZODlQYWtBN0Z1N0pTZVo2eEMtckNEcQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SPCX Stock (SPTX) Opinions on post-IPO performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQQkpxTW00S0Vpbm9haG1IUWJIZW9CVUpJYlpDMUd3cTA0TlFTYnVicXdhS2plWkxNQUZCYVoxRHcwNjhkM2Z2Wkl2SW1NYzdib2hSMDRiZlVKcjNKRWZoTnNDMHdHSnlpN1RjLTh6TzdhbG9nUDNJMmlnNEZUa1RHanptNlY1bENyb2o4R2s5OG8?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo\u2122 in Healthy Volunteers", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/puretech-founded-entity-seaport-therapeutics-060000179.html", "source_name": "Business Wire", "published_at": "2026-06-09T06:00:00+00:00", "published_display": "09 Jun 2026 06:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Q1 Net Loss Widens", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-q1-net-loss-113204320.html", "source_name": "MT Newswires", "published_at": "2026-06-08T11:32:04+00:00", "published_display": "08 Jun 2026 11:32", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-reports-first-quarter-110500729.html", "source_name": "Business Wire", "published_at": "2026-06-08T11:05:00+00:00", "published_display": "08 Jun 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo\u2122 in Healthy Volunteers", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-reports-positive-multiple-110000111.html", "source_name": "Business Wire", "published_at": "2026-06-08T11:00:00+00:00", "published_display": "08 Jun 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics reports Q1 2026 financials and pipeline progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNZ2lFTHVBZnFKOXRyMVJScFBrMUVEb3BzUzFmUnV1aV81SHRDQXRMSVQzMl83d1VlaDhQMVo1V0xhUUxUMEZ6Q2Zub1VET0hpSy10Slc1NkFaOGdBZGI5SXgyLUc4UURqdDg0R0tIcFpkSjNObm5UZ2xjS3lqYWw2ME44QmJIQQ?oc=5", "source_name": "grafa.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics to Participate in Two Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/seaport-therapeutics-participate-two-upcoming-110000262.html", "source_name": "Business Wire", "published_at": "2026-06-01T11:00:00+00:00", "published_display": "01 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5yX3VBVjZ2VWktenFoVVZGb0hQMm80aE0tcGt2ek1zdDNPOW50RkRNRXM2dThzYThOYlBleG9EZnJ3TjgzaTZwMnZZUTlqMzhCbW45SnVmWUFxU0RtYzhuTjVKNkNEdw?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-26T12:07:48+00:00", "published_display": "26 May 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Seaport Therapeutics stock coverage citing platform validation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNcUI3T1RCU1VrVGs0S3Z1VjFIVUlKdFlqVVN1aXo5dklfNW52akZHTTU0dFA5aDdjWk0ybU9lMG80UnZxcEh4WnI3dHRaRHozQndDcmhmQ25oMUZBak83eHN2TnIzcFlQaExEckhEREE5VnNxemxRMmljcW9uOWZFdEdhN2VoSHdKY0RQdk1jc2h4VjA2b1E5alRqQlJKX09QZktxcHJxN2wwUG1idjBRNFNyczh4QkktcDJyUGlmYkJMRmdySHljZC1BaTVXWHluUUt1ZXV6aU9tbDRNdElB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock markets resemble peak of dot-com bubble, warns Burry", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNQ2U0dlRDV25wVWs0THJoY0l5U1pMYmdiVkpfUUhoTUxSdjJndElCX1l1V2tNamRIcWhJaEk3eUxXeWRSTGFTb19aR3FvTUZhV05mM1RySUlaWE54Tmd5VlpVWm9KV1ZXR1NGYjFxMDRuQjhZODcxU0RjcnVWNUdHTng4Q1hCcHFydW1NUnp0UEdJRkJzeGFSel85ZWFoZDQxZnZldS10Mk9YV3VIVTV2akJYLWE0VUE?oc=5", "source_name": "Irish Independent", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBKU0lRRDk5Z19uT1B0aTVKcV9ucGtHVDRTQnA1ekxEZTB1NWtwc3JrVWlWeEJBNkFmaTB3RVl6RjE1eUJvamJMb1F1NGRmdEpu?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-04T23:22:23+00:00", "published_display": "04 May 2026 23:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics, Inc (SPTX) Stock Price Today: $20.10", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBDVGJORUVuQmsyN2tPLWR3bmRYcER1bWxsdFNjU2Vra21fcFptUFZpWXZTekR0RlVVLTR5bW5rSC1hTldTXzNEejZOWHNISk1FZFVvX0xsYw?oc=5", "source_name": "Gotrade", "published_at": "2026-05-04T19:48:25+00:00", "published_display": "04 May 2026 19:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9GSnRyNkhiZl9lYjBRemg0QlZ5ZklsRS15TWJodW5ORXlRWnlLS1FoTUVTWVRkZDFkXzlDdzRTSzBjdmh6Ql93c2o5RzNXeVU4NGY0RHBVamRnenlXOUgzZGxtNmNIZDZqdldpajFkeHZFSEpFaHc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-04T15:33:22+00:00", "published_display": "04 May 2026 15:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQSy1hbVAtWjUzOFprWWs0bkFGekYxUmhpT2FRWTZmVVQ1eXdwVC1MUmZreDNYR3hpSGpYZ3BaYlJjcnhmX1BsQmJGWDcyNENjQXpFYndWd0RqRVR4TXJaZWxKeGZ2OGhPYUJzTmZJQTVUTEN6UzZFa0hCQWU1YlpvMHZBUU45MkZ4US1lcGVzZXBZR0FRX3VhdDF6aGoxRjBRSjhZdEVBUU9qV041S293?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics (SPTX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9raUYxX2pFZnktdWEyZXZVdmVIYlo2eThTYVhCM3RPb0FGbS12bDM2a1lVQnRiRlhJNWZUZF9nVTJqN2RuWS03dGlwdGRlOGFOU2pEVnhEbzZrQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T23:25:39+00:00", "published_display": "02 May 2026 23:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Rings the Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1Bb0psVUZyelBId2hVVUFZbUpQdkJCOEFnYm9BVnk2U29SSDY4SHJDVG04ZmZNUmdQejRTNXBUdW5BdGsyTzN1QVpfRWNGNUxycXRPMURReFBvSFdpUGYyTVhNMm5TaDlfYlVJQ0I5RU8xbXgxUEZEXw?oc=5", "source_name": "Nasdaq", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab price upsized IPOs eyeing $550M in proceeds", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1RNC0tOXZWMktULU5ad1VkZHZzTlpsSFZobi04clIzblNQcFdCU1ltT1dKNGd2c0tUdDFaMURnUTVycC1rYzd5amFsdmQ4Y296Uk9kZU84TVVRQk0yY1lrOGtzQjNHUC1LZTA4bnJRV0tiVjREaDNzS0FR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPeDgtMUt3RVUzaDBTTGxHWmthOGlRNTJRM0xOYVFlaEVDOG0tVXYxM216Q0VwLUI5SnNIV1VRSTFQdWxNSUtOdmxyVDZiOHhsZWZNTHhadzliOXl1RWszR3VXT1U3RkJ2QWVyemNXTlFfOHdGcUthdUtBbmN0OVNlbzh4cmtKVU45ZUR5TzlvekVfbnNOZjhKZ0pwejlZR2pDM3huUWdndDQxTkhoN2hLZGRZdGRIb3ZHczhwMlBkdTFWREYtWjdNRzlR?oc=5", "source_name": "Business Wire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE81ZVdma2hyMUdWZ0FBNjBKamJOM1pvY1p6LTBqbURqWUU4bS1QcEp5UFNKMThPc3hvNVRkOUtVcVhkLXFuTk9kLUU4Q2tVZzNv?oc=5", "source_name": "CNN", "published_at": "2026-04-28T17:29:39+00:00", "published_display": "28 Apr 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab launch US IPOs as biotech listings gather momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPTnlOQkR4VkhDYnZXbHlLTjktQ3c3UGlKX0dMdzNFcEJQcDczREs5alNJRDFwNWhqajZaSjNCS3k2NTIzZVpqVG9zUy05QnNETklpYjNDclJQUG5vRmg0Y25IZ1B3Z3JndVdqUmpYN1c4eVljWkFxbHVqc0VQZHJ3Sy11TGZBUU1OWjNWVlk0WjQ2SnFLZ215TXNNRm15eHZWaU9wMU1tQWlJX2d1R2hLbkRpVHZjMjMtSW4wMVpCTFhNR1k?oc=5", "source_name": "Reuters", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drug developer Seaport Therapeutics seeks up to $212M in US IPO (SPTX:Pending)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOQjFvbnR4SnF3TnVsRElFRGdtblFKR0x5eWMzcDJLdGlpR29VbDRYU3B0MlVkeXM2Z1pUVmM4TTFJRkJZVlNvVjZQTlZQNm4xSTMxRGJYYmxvaUFjSUFscDdDOW5aQU9yRllZa3JGSnk5UjUwaWUwaW5oSDhrWll1aTFDd3RIMWRiRVZ4Qk5pWDkwQUUwQlJyOGdxdGhqQWF1cUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SPTX Stock Price and Chart \u2014 NASDAQ:SPTX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1OY0hLNmhLSGY5OEpES1daVW5oV3FJY3pBbFdJMEZsRHFvUFJxaHdqNm4tNk1BdHBkVWJsNEVoenpGTVFEU0g0X19MRnIzbFhhVEhueFFJdXhxV1Ji?oc=5", "source_name": "TradingView", "published_at": "2026-04-14T10:27:06+00:00", "published_display": "14 Apr 2026 10:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 70, "total_relevant": 47, "sentiment_summary": {"positive": 8, "negative": 3, "neutral": 36, "score": 52, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 15.7, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 8.05, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 8, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 20.85, "latest_week": "2026-07-17", "one_week_move": -3.4, "four_week_move": 14.7, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 11.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 70.9804, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.4% over one week, +14.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "MarketBeat", "count": 6}, {"label": "Business Wire", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Quiver Quantitative", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Seeking Alpha", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 16}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.4% over one week, +14.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Seaport Therapeutics (SPTX) Earnings Date and Reports 2026"}], "updated_at": "2026-07-23T02:34:27.482148+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}